Expression and Vascular Effects of Cyclooxygenase-2 in Brain
Author(s) -
Johnny E. Brian,
Steven A. Moore,
Frank M. Faraci
Publication year - 1998
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.29.12.2600
Subject(s) - medicine , in vivo , cyclooxygenase , western blot , dexamethasone , lipopolysaccharide , cerebrospinal fluid , leptomeninges , prostaglandin , prostaglandin e2 , endocrinology , microglia , pharmacology , inflammation , central nervous system , biology , biochemistry , enzyme , microbiology and biotechnology , gene
Cyclooxygenase-2 (COX-2) is an inducible isoform of cyclooxygenase. Several types of brain cells in culture can express COX-2 when treated with lipopolysaccharide (LPS) or some cytokines. LPS produces dilatation of cerebral arterioles in vivo through a mechanism that is partially inhibited by indomethacin. In the present study we examined the hypothesis that LPS causes increased expression of COX-2 in brain as well as COX-2-dependent dilatation of cerebral arterioles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom